Another paper in Diabetologia by Yoshiyuki Hattori has been retracted for image duplication, marking the second of his articles in the journal to be pulled for that reason. The notice for the article, “A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells,” states:
An HIV researcher in Germany has run afoul of a number of journals because he duplicated his papers in multiple outlets. The funny business by Ulrich Hengge earned him a 3-year ban on publishing in two journals, the Journal of Molecular Medicine (JMM) and Cells, Tissues and Organs (CTO). (We’ve written about publishing bans — which … Continue reading Duplication earns German HIV researchers a retraction, and a 3-year publishing ban
A retraction notice appeared a few months ago in the Biophysical Journal: This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of Edward Egelman, Editor-in-Chief. The editors have noted that there is a substantial overlap of figures and text between this Biophysical Journal … Continue reading Why editors should stop ignoring anonymous whistleblowers: Our latest LabTimes column
The journal Chemosphere has retracted two papers over authorship concerns. The problem is, we don’t really know what those concerns are. Here’s one notice:
There’s an unhelpful retraction notice online in the journal Antioxidants & Redox Signaling, a Mary Ann Liebert publication. The paper, “Inhibition of LXRalpha-dependent steatosis and oxidative injury by liquiritigenin, a licorice flavonoid, as mediated with Nrf2 activation,” has been removed from the site, except for the abstract, which now has this in front of it: THIS WORK HAS BEEN RETRACTED … Continue reading Reason behind opaque Antioxidants & Redox Signaling retraction notice revealed
The American Journal of Obstetrics and Gynecology (AJOG) as a remarkable retraction notice in its November issue — the likes of which we haven’t seen before. A little background: Earlier this year, Laurence Cole, an academic obstetrics specialist at the University of New Mexico in Albuquerque, published a paper in the AJOG looking at the wide … Continue reading Ob-gyn journal pulls pregnancy test paper for undeclared conflict of interest, other problems
The American Journal of Physiology Endocrinology and Metabolism is retracting a 2009 article by Japanese researchers who appeared to be so fond of their data they published them thrice. The paper, “Dual suppression of adipogenesis by cigarette smoke through activation of the aryl hydrocarbon receptor and induction of endoplasmic reticulum stress,” by Masanori Kitamura and … Continue reading A retraction as a group’s papers on smoking and weight loss are too close for comfort
Last March, the journal Genomics retracted a paper, “Discovery of transcriptional regulators and signaling pathways in the developing pituitary gland by bioinformatic and genomic approaches,” for reasons that don’t really fit into a tight lede sentence. Let’s just say that at times the problems involved both questions of authorship and the validity of the research. More … Continue reading Retracted retraction leaves Genomics paper intact — but authors wonder if anyone will know
From the, No Further Explanation Required files: The journal Animal Behaviour has retracted a 2009 article by an international group of researchers who, well, did just about everything one could do wrong with a paper. Here’s the notice, res ipsa loquitur:
We can only imagine how Joe Hollyfield felt to learn from us, of all people, that his journal, Experimental Eye Research, had retracted two manuscripts in a recent issue. The papers, “Mechanisms of retinal ganglion cell injury and defense in glaucoma,” by Qu J, Wang D, and Grosskreutz CL, and “Mitochondria: Their role in ganglion cell … Continue reading Publisher error handling two eye papers leads to retractions, new policy on notices